For some patients, a daily habit is easier to build and maintain
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE/ mouse model
The GH/IGF-1 axis is highly sensitive to small changes in GH or IGF-1 2 levels, which can trigger feedback suppression or amplify downstream effects
Treatment with retatrutide 4 mg, 9 mg, and 12 mg led to an average weight loss of 29.8 lbs (12.7%), 45.4 lbs (19.1%), and 49.6 lbs (20.8%), respectively, in the given patient population, at 80 weeks
The study further highlighted growing indications that the producers of these weight loss medications were aware of the possible adverse reactions
As these therapies reshape treatment approaches for obesity and potentially a range of other chronic conditions, theyre also prompting questions about access, long-term outcomes, and the future of innovation in chronic disease care
